Eisenmenger's Syndrome in Adults With CHD

Completed

Conditions studied: Congenital Disorders

In brief

Review the outcome of treatment with endothelin receptor antagonists (bosentan or sitaxsetan) alone or in combination with Sildenafil (a PDE-5 inhibitor) in adult patients with pulmonary hypertension due to congenital heart disease.

Key facts

Study ID

NCT00266903

Run by

Children's Healthcare of Atlanta

People needed

48

Starts

1996-01-01

Expected to finish

2008-01-01

Last updated by the study team

2014-12-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Congenital heart disease (unoperated, palliated or repaired) Eisenmenger's syndrome Age 18 to 80

You may not qualify if…

• Those who do not meet inclusion criteria

Where it is running

• Children's Healthcare of Atlanta — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.